ArticleScientific reports2025
Predictive modeling of asthma drug properties using machine learning and topological indices in a MATLAB based QSPR study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Interpretable QSPR Modeling of Bipolar Disorder Drugs Using Topological Indices and Machine Learning Regression.ACS omega · 2026Article
- Organic Chemistry as a Catalyst for AI Innovation: Challenges, Methods, and Emerging Paradigms.Chemical reviews · 2026Review
- Mathematical Modeling and Computation of NM-Polynomial Indices for Physicochemical Properties Prediction.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning is a vital tool in advancing drug development by accurately predicting the physical, chemical, and biological properties of various compounds. This study utilizes MATLAB program-based algorithms to calculate topological indices and machine learning algorithms to explore their ability to predict the physio-chemical properties of asthma drugs. By combining machine learning with topological indices, we can conduct faster and more precise analyses of drug structures. As we deepen our understanding of the relationship between molecular structure and performance, the integration of machine learning with QSPR research highlights the significant potential of computational strategies in pharmaceutical discovery. The use of machine learning algorithms such as random forest and extreme gradient boosting is essential in this process. These algorithms leverage labeled data to predict complex molecular processes, aiding in the discovery of new medication options and enhancing their properties. These methods enhance the accuracy of physical and chemical property predictions, streamline the drug discovery process, and efficiently evaluate large datasets through machine learning. Ultimately, these advancements facilitate the development of innovative and effective treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.